Related Experiment Video
Updated: Dec 31, 2025
Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors
Published on: December 3, 2013
Development of a Novel Oncolytic Adenovirus Expressing a Short-hairpin RNA Against Cullin 4A
Keisaku Wakabayashi1, Fuminori Sakurai2, Ryosuke Ono1
1Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
Background:
Arming of an oncolytic adenovirus (OAd) by inserting expression cassettes of therapeutic transgenes into the OAd genome is a promising approach to enhance the therapeutic effects of an OAd. Ideally, this approach would simultaneously promote the replication of an OAd in tumor cells and transgene product-mediated antitumor effects by expressing therapeutic transgenes. We previously demonstrated that knockdown of cullin 4A (CUL4A), which is an E3 ubiquitin ligase, significantly promoted adenovirus replication by increasing the c-JUN protein level. In addition, previous studies reported that CUL4A was highly expressed in various types of tumor, and was involved in tumor growth and metastasis.
Materials And Methods:
In this study, we developed a novel OAd expressing a short-hairpin RNA (shRNA) against CUL4A (OAd-shCUL4A).
Results:
OAd-shCUL4 mediated higher levels of cytotoxic effects on various types of human tumor cell than a conventional OAd. Higher levels of OAd genome copy numbers were found in the tumor cells for OAd-shCUL4A, compared with a conventional OAd.
Conclusion:
OAd-shCUL4A showed efficient antitumor effects by both enhancing OAd replication and inhibiting tumor cell growth.
Insights
This study developed a novel oncolytic adenovirus (OAd) expressing shRNA against cullin 4A (CUL4A). This enhanced OAd demonstrated superior antitumor effects by increasing viral replication and inhibiting tumor cell growth.
Area of Science:
- Oncolytic virotherapy
- Gene therapy
- Cancer research
Background:
- Oncolytic adenoviruses (OAd) can be armed with therapeutic transgenes to enhance antitumor effects.
- Cullin 4A (CUL4A) is highly expressed in tumors and promotes tumor growth.
- CUL4A knockdown enhances adenovirus replication by increasing c-JUN levels.
Purpose of the Study:
- To develop a novel OAd expressing shRNA against CUL4A (OAd-shCUL4A).
- To evaluate the antitumor efficacy of OAd-shCUL4A compared to conventional OAd.
Main Methods:
- Development of a recombinant OAd vector expressing short-hairpin RNA (shRNA) targeting CUL4A.
- In vitro assessment of cytotoxic effects on human tumor cell lines.
- Quantification of OAd genome copy numbers in infected tumor cells.
Main Results:
- OAd-shCUL4A exhibited significantly higher cytotoxic effects against various human tumor cells compared to conventional OAd.
- Increased OAd genome copy numbers were observed in tumor cells treated with OAd-shCUL4A.
- CUL4A knockdown enhanced OAd replication and inhibited tumor cell proliferation.
Conclusions:
- OAd-shCUL4A demonstrates potent antitumor activity through enhanced viral replication and direct inhibition of tumor cell growth.
- Targeting CUL4A represents a promising strategy for improving the efficacy of oncolytic adenovirus therapy.
